Literature DB >> 26844919

Massively parallel sequencing of forensic STRs: Considerations of the DNA commission of the International Society for Forensic Genetics (ISFG) on minimal nomenclature requirements.

Walther Parson1, David Ballard2, Bruce Budowle3, John M Butler4, Katherine B Gettings4, Peter Gill5, Leonor Gusmão6, Douglas R Hares7, Jodi A Irwin7, Jonathan L King8, Peter de Knijff9, Niels Morling10, Mechthild Prinz11, Peter M Schneider12, Christophe Van Neste13, Sascha Willuweit14, Christopher Phillips15.   

Abstract

The DNA Commission of the International Society for Forensic Genetics (ISFG) is reviewing factors that need to be considered ahead of the adoption by the forensic community of short tandem repeat (STR) genotyping by massively parallel sequencing (MPS) technologies. MPS produces sequence data that provide a precise description of the repeat allele structure of a STR marker and variants that may reside in the flanking areas of the repeat region. When a STR contains a complex arrangement of repeat motifs, the level of genetic polymorphism revealed by the sequence data can increase substantially. As repeat structures can be complex and include substitutions, insertions, deletions, variable tandem repeat arrangements of multiple nucleotide motifs, and flanking region SNPs, established capillary electrophoresis (CE) allele descriptions must be supplemented by a new system of STR allele nomenclature, which retains backward compatibility with the CE data that currently populate national DNA databases and that will continue to be produced for the coming years. Thus, there is a pressing need to produce a standardized framework for describing complex sequences that enable comparison with currently used repeat allele nomenclature derived from conventional CE systems. It is important to discern three levels of information in hierarchical order (i) the sequence, (ii) the alignment, and (iii) the nomenclature of STR sequence data. We propose a sequence (text) string format the minimal requirement of data storage that laboratories should follow when adopting MPS of STRs. We further discuss the variant annotation and sequence comparison framework necessary to maintain compatibility among established and future data. This system must be easy to use and interpret by the DNA specialist, based on a universally accessible genome assembly, and in place before the uptake of MPS by the general forensic community starts to generate sequence data on a large scale. While the established nomenclature for CE-based STR analysis will remain unchanged in the future, the nomenclature of sequence-based STR genotypes will need to follow updated rules and be generated by expert systems that translate MPS sequences to match CE conventions in order to guarantee compatibility between the different generations of STR data.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  MPS; Massively parallel sequencing; NGS; Next generation sequencing; Nomenclature; STRs; Short tandem repeats

Mesh:

Substances:

Year:  2016        PMID: 26844919     DOI: 10.1016/j.fsigen.2016.01.009

Source DB:  PubMed          Journal:  Forensic Sci Int Genet        ISSN: 1872-4973            Impact factor:   4.882


  37 in total

1.  Sequence-based US population data for the SE33 locus.

Authors:  Lisa A Borsuk; Katherine B Gettings; Carolyn R Steffen; Kevin M Kiesler; Peter M Vallone
Journal:  Electrophoresis       Date:  2018-06-01       Impact factor: 3.535

2.  Analysis of 21 X-chromosome polymorphisms in urban and rural populations in Salta province (north-western Argentina).

Authors:  J F Ferragut; M Bassitta; V Torrens; V Albeza; N Acreche; J A Castro; C Ramon; A Picornell
Journal:  Int J Legal Med       Date:  2018-11-16       Impact factor: 2.686

3.  Characterization of new chloroplast markers to determine biogeographical origin and crop type of Cannabis sativa.

Authors:  Madeline G Roman; David Gangitano; Rachel Houston
Journal:  Int J Legal Med       Date:  2019-08-23       Impact factor: 2.686

4.  Analyzing population structure for forensic STR markers in next generation sequencing data.

Authors:  Sanne E Aalbers; Michael J Hipp; Scott R Kennedy; Bruce S Weir
Journal:  Forensic Sci Int Genet       Date:  2020-08-12       Impact factor: 4.882

5.  STRSeq: A catalog of sequence diversity at human identification Short Tandem Repeat loci.

Authors:  Katherine Butler Gettings; Lisa A Borsuk; David Ballard; Martin Bodner; Bruce Budowle; Laurence Devesse; Jonathan King; Walther Parson; Christopher Phillips; Peter M Vallone
Journal:  Forensic Sci Int Genet       Date:  2017-09-01       Impact factor: 4.882

6.  Estimation of the number of contributors to mixed samples of DNA by mitochondrial DNA analyses using massively parallel sequencing.

Authors:  Hiroaki Nakanishi; Koji Fujii; Hiroaki Nakahara; Natsuko Mizuno; Kazumasa Sekiguchi; Katsumi Yoneyama; Masaaki Hara; Aya Takada; Kazuyuki Saito
Journal:  Int J Legal Med       Date:  2019-11-12       Impact factor: 2.686

Review 7.  Current issues for mammalian species identification in forensic science: a review.

Authors:  Chikahiro Mori; Shuichi Matsumura
Journal:  Int J Legal Med       Date:  2020-06-19       Impact factor: 2.686

8.  Sequence-based U.S. population data for 27 autosomal STR loci.

Authors:  Katherine Butler Gettings; Lisa A Borsuk; Carolyn R Steffen; Kevin M Kiesler; Peter M Vallone
Journal:  Forensic Sci Int Genet       Date:  2018-07-19       Impact factor: 4.882

9.  Assessment of impact of DNA extraction methods on analysis of human remain samples on massively parallel sequencing success.

Authors:  Xiangpei Zeng; Kyleen Elwick; Carrie Mayes; Maiko Takahashi; Jonathan L King; David Gangitano; Bruce Budowle; Sheree Hughes-Stamm
Journal:  Int J Legal Med       Date:  2018-10-19       Impact factor: 2.686

10.  Report from the STRAND Working Group on the 2019 STR sequence nomenclature meeting.

Authors:  Katherine Butler Gettings; David Ballard; Martin Bodner; Lisa A Borsuk; Jonathan L King; Walther Parson; Christopher Phillips
Journal:  Forensic Sci Int Genet       Date:  2019-09-21       Impact factor: 4.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.